Suffolk Capital Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $8.31M | Buy |
230,149
+22,679
| +11% | +$819K | 1.59% | 39 |
|
|
2018
Q3 | $12.8M | Sell |
207,470
-4,058
| -2% | -$250K | 1.82% | 27 |
|
|
2018
Q2 | $14.3M | Sell |
211,528
-2,717
| -1% | -$184K | 2.04% | 12 |
|
|
2018
Q1 | $11.6M | Sell |
214,245
-41,204
| -16% | -$2.24M | 1.65% | 26 |
|
|
2017
Q4 | $15.3M | Sell |
255,449
-28,058
| -10% | -$1.68M | 1.98% | 9 |
|
|
2017
Q3 | $13.8M | Buy |
283,507
+137,654
| +94% | +$6.69M | 1.82% | 20 |
|
|
2017
Q2 | $7.67M | Buy |
145,853
+128,760
| +753% | +$6.77M | 1.01% | 45 |
|
|
2017
Q1 | $775K | Sell |
17,093
-20,844
| -55% | -$945K | 0.1% | 120 |
|
|
2016
Q4 | $1.44M | Buy |
37,937
+4,032
| +12% | +$153K | 0.2% | 103 |
|
|
2016
Q3 | $1.28M | Sell |
33,905
-85,100
| -72% | -$3.21M | 0.18% | 120 |
|
|
2016
Q2 | $2.09M | Buy |
+119,005
| New | +$2.09M | 0.27% | 114 |
|